Anthropic and Microsoft in Talks for AI Chip Deal Following 5 Billion Investment Precious Metals Retreat as US Dollar Strength Persists Key Levels for Potential Recovery Asia Pacific Real Estate Investment Surges 19 in Q1 India Emerges as Key Logistics and Data Centre Hub Savills Report AI Boom Strains Optical Tech Supply Chains as Huawei Stages Chip Comeback Amazon Health Leadership ShakeUp Dr Roy Schoenberg to Replace Outgoing Executive ProSiebenSat1 Media AGM Highlights Entertainment Strategy Shift and Cost Efficiency Plans Euronet Worldwide EEFT Q1 2026 Earnings EPS Beat Drives Nuanced Outlook Amid Broader Market Headwinds MTDR Q1 2026 Earnings Strong EPS Beat Boosts Investor Sentiment Liberty Live Holdings Inc Series A LLYVA Q4 2025 Earnings EPS Falls Just Short of Estimates Stock Slightly Lower UGI Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Operational Resilience RDHL Q2 2022 Earnings Significant EPS Miss Despite Stock Gain ETOR Q1 2026 Earnings Earnings Beat Expectations with 2342 Surprise Ernexa Therapeutics ERNA Slips 38 as Shares Test Key Support Near 1139 Jones Lang LaSalle JLL Holds Steady Near Support as Volume Remains Subdued BHP Group BHP Inching Higher Can the Mining Giant Break Above Resistance Perpetualscom Ltd PDC Slides 79 as Selling Pressure Intensifies CaliberCos Inc CWD Slides 211 as Stock Approaches Critical Support at 088 Trump Family News President Skipping Son Donald Jrs Wedding to Bettina Anderson SGLY Q3 2019 Earnings Significant EPS Miss Amid Missing Revenue Figures Open Lending LPRO Surges 87 as Stock Tests Key Resistance at 222 Richardson Electronics RELL Declines 423 Support at 1591 Becomes Key Level Werewolf Therapeutics HOWL Stages a Modest Rebound Can the 044 Level Hold Nuveen California Municipal Income Fund NKX Records Modest Gain as Yield Environment Stabilizes Jupiter Neurosciences JUNS Stages a Sharp Rebound from Support Testing Key Resistance Velocity Financial VEL Consolidates Near 1743 as Traders Eye Support and Resistance Levels Blue Bird Corporation BLBD Slips 181 as Shares Test Key Support Levels AIM ImmunoTech AIM Slides Nearly 5 as Stock Approaches Key Support at 022